A meta-analysis combining data from the DECISION clinical trial with two earlier randomized studies found hospitalizations were reduced by 25% achieved by a reduction in worsening heart failure events. The post Low‑Dose Digoxin Shows Benefit in Heart Failure Treatment appeared first on Inside Precision Medicine .